PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
UDOW vs. CURE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between UDOW and CURE is 0.72, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


-0.50.00.51.00.7

Performance

UDOW vs. CURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares UltraPro Dow30 (UDOW) and Direxion Daily Healthcare Bull 3x Shares (CURE). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%20.00%30.00%AugustSeptemberOctoberNovemberDecember2025
22.13%
-16.97%
UDOW
CURE

Key characteristics

Sharpe Ratio

UDOW:

1.29

CURE:

-0.15

Sortino Ratio

UDOW:

1.84

CURE:

0.02

Omega Ratio

UDOW:

1.23

CURE:

1.00

Calmar Ratio

UDOW:

2.21

CURE:

-0.13

Martin Ratio

UDOW:

5.83

CURE:

-0.34

Ulcer Index

UDOW:

7.69%

CURE:

14.69%

Daily Std Dev

UDOW:

34.73%

CURE:

33.15%

Max Drawdown

UDOW:

-80.29%

CURE:

-69.19%

Current Drawdown

UDOW:

-8.09%

CURE:

-28.86%

Returns By Period

The year-to-date returns for both stocks are quite close, with UDOW having a 9.94% return and CURE slightly lower at 9.84%. Over the past 10 years, UDOW has outperformed CURE with an annualized return of 20.60%, while CURE has yielded a comparatively lower 12.02% annualized return.


UDOW

YTD

9.94%

1M

7.19%

6M

22.13%

1Y

38.72%

5Y*

10.29%

10Y*

20.60%

CURE

YTD

9.84%

1M

9.96%

6M

-16.97%

1Y

-6.20%

5Y*

6.10%

10Y*

12.02%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


UDOW vs. CURE - Expense Ratio Comparison

UDOW has a 0.95% expense ratio, which is lower than CURE's 1.08% expense ratio.


CURE
Direxion Daily Healthcare Bull 3x Shares
Expense ratio chart for CURE: current value at 1.08% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.08%
Expense ratio chart for UDOW: current value at 0.95% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.95%

Risk-Adjusted Performance

UDOW vs. CURE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UDOW
The Risk-Adjusted Performance Rank of UDOW is 5353
Overall Rank
The Sharpe Ratio Rank of UDOW is 5050
Sharpe Ratio Rank
The Sortino Ratio Rank of UDOW is 4848
Sortino Ratio Rank
The Omega Ratio Rank of UDOW is 4949
Omega Ratio Rank
The Calmar Ratio Rank of UDOW is 6565
Calmar Ratio Rank
The Martin Ratio Rank of UDOW is 5151
Martin Ratio Rank

CURE
The Risk-Adjusted Performance Rank of CURE is 55
Overall Rank
The Sharpe Ratio Rank of CURE is 55
Sharpe Ratio Rank
The Sortino Ratio Rank of CURE is 66
Sortino Ratio Rank
The Omega Ratio Rank of CURE is 66
Omega Ratio Rank
The Calmar Ratio Rank of CURE is 44
Calmar Ratio Rank
The Martin Ratio Rank of CURE is 55
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

UDOW vs. CURE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares UltraPro Dow30 (UDOW) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for UDOW, currently valued at 1.29, compared to the broader market0.002.004.001.29-0.15
The chart of Sortino ratio for UDOW, currently valued at 1.84, compared to the broader market0.005.0010.001.840.02
The chart of Omega ratio for UDOW, currently valued at 1.23, compared to the broader market1.002.003.001.231.00
The chart of Calmar ratio for UDOW, currently valued at 2.21, compared to the broader market0.005.0010.0015.0020.002.21-0.13
The chart of Martin ratio for UDOW, currently valued at 5.83, compared to the broader market0.0020.0040.0060.0080.00100.005.83-0.34
UDOW
CURE

The current UDOW Sharpe Ratio is 1.29, which is higher than the CURE Sharpe Ratio of -0.15. The chart below compares the historical Sharpe Ratios of UDOW and CURE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.00AugustSeptemberOctoberNovemberDecember2025
1.29
-0.15
UDOW
CURE

Dividends

UDOW vs. CURE - Dividend Comparison

UDOW's dividend yield for the trailing twelve months is around 0.86%, less than CURE's 1.06% yield.


TTM20242023202220212020201920182017201620152014
UDOW
ProShares UltraPro Dow30
0.86%0.95%0.95%0.83%0.26%0.19%0.61%0.73%0.13%0.78%0.21%0.46%
CURE
Direxion Daily Healthcare Bull 3x Shares
1.06%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%0.00%0.00%0.00%

Drawdowns

UDOW vs. CURE - Drawdown Comparison

The maximum UDOW drawdown since its inception was -80.29%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for UDOW and CURE. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-8.09%
-28.86%
UDOW
CURE

Volatility

UDOW vs. CURE - Volatility Comparison

ProShares UltraPro Dow30 (UDOW) has a higher volatility of 13.82% compared to Direxion Daily Healthcare Bull 3x Shares (CURE) at 11.69%. This indicates that UDOW's price experiences larger fluctuations and is considered to be riskier than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


6.00%8.00%10.00%12.00%14.00%16.00%AugustSeptemberOctoberNovemberDecember2025
13.82%
11.69%
UDOW
CURE
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab